highly significantp < 0.001
In contrast, PRF demonstrated partial clinical dissolution at week 1 (22.47%) and near-complete clinical dissolution by week 2 (83.67%), with a highly significant group difference ( p < 0.001).
In contrast, PRF demonstrated partial clinical dissolution at week 1 (22.47%) and near-complete clinical dissolution by week 2 (83.67%), with a highly significant group difference ( p < 0.001).